4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-029566
Chief R&D Officer gave up 7,150 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Thackray Helen M. · Chief R&D Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-14 | Shares withheld for taxes : show line 1 in the form | −7,150 | $7.53 | $53,840 | 264,989 | D |
Loading xslF345X05/form4.xml…